|
FY2025
12 months to Dec 31, 2025
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|
| Revenue | ||
| Cost of product sales | ||
| Research and development expenses | ||
| Selling, general and administrative expenses | ||
| Acquisition and integration related charges | ||
| Total costs and operating expenses | ||
| Operating profit | ||
| Financial income | ||
| Financial expenses | ||
| Net profit before tax | ||
| Corporate tax | ||
| Net profit | ||
| Other comprehensive income: | ||
| Amounts which may be re-classified to the income statement: | ||
| Exchange differences on translation of foreign operations | ||
| Total comprehensive income | ||
| Basic net profit per share (in dollars per share) | ||
| Diluted net profit per share (in dollars per share) | ||
Loading...
